Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Research Article

Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs

Author(s): Saganuwan A. Saganuwan*

Volume 20, Issue 1, 2020

Page: [3 - 12] Pages: 10

DOI: 10.2174/1871524919666190621160323

Abstract

Background: Benzimidazole (albendazole), imidazothiazole (levamisole) and imidazole (euconazole) are used in chemotherapy of helminthosis and mycosis respectively, with central nervous system (CNS) side effects. But only a limited number of azole groups are used clinically in the treatment of CNS diseases, which are on increase and could not be cured permanently. Due to increased incidence of more challenging new CNS diseases, there is a need for the synthesis of more potent CNS drugs.

Methods: Hence, literature studies were carried out for the identification of common pathways for the synthesis of the three groups of compounds, their CNS properties and the possibility of modifying them to potent CNS drugs.

Results: Findings have shown that gloxal with formaldehyde in the presence of ammonia can be converted into imidazole, imidazothiazole and benzimidazole via distillation, condensation, alkylation, acylation, oxidation, cyclization, sulphation and amidation. However, agents such as phosphorus pentoxide, ethanolic potassium hydroxide, sodium hypochlorite, sodium hexafluroaluminate, aniline, calcium acetate, calcium benzoate, sodium hydroxide, aromatic aldehydes, bromoketones, alpha dicarbonyl compounds among others are used as reagents. The furan ring(s) may have a strong capability of penetrating CNS for the treatment of neurological disorders. The products from the three groups have agonistic, antagonistic, mixed agonistic and mixed antagonistic depressant and stimulant activities due to the presence of heteroatoms such as nitrogen, oxygen and sulphur. Imidazole may be the most potent with best characteristics of CNS penetrability and activity followed by imidazothiazole and benzimidazole.

Conclusion: Azole group is common to all the three classes and may be responsible for some of their CNS effects. The resultant compounds could act via all neurotransmitters, voltage and ligand-gated ion channels and may be chiral.

Keywords: Azole, brain, drug, medicinal chemistry, neuropsychopharmacology, neurodegenerative disease.

Graphical Abstract

[1]
Babizhayev, M.A. Biochemical, biomedical and metabolic aspects of imidazole-containing dipeptides with the inherent complexity to neurodegenerative diseases and various states of mental well-being: A challenging correction and neurotherapeutic pharmaceutical biotechnology for treating cognitive deficits, depression and intellectual disabilities. Curr. Pharm. Biotechnol., 2014, 15(8), 738-778.
[http://dx.doi.org/10.2174/1389201015666140827104918] [PMID: 25158972]
[2]
Sy, G.Y.; Bruban, V.; Bousquet, P.; Feldman, J. Nitric oxide and central antihypertensive drugs: One more difference between catecholamines and imidazolines. Hypertension, 2001, 37(2), 246-249.
[http://dx.doi.org/10.1161/01.HYP.37.2.246] [PMID: 11230279]
[3]
Bano, K.; Naeem, S.; Siddiqui, N.A.; Minhas, N.; Akhtar, N. Computer aided drug design of imidazole free acylpiperazine derivative as a histamine H3 receptor antagonist. Pak. J. Biochem. Mol. Biol., 2012, 45(3), 154-158.
[4]
Filippelli, A.; Cuparencu, B.; Berrino, L.; Tomus, C.; Rossi, F. The influence of imidazole administration on arrhythmias induced by potassium chloride, calcium chloride and ouabain in isolated guinea pig hearts. Curr. Therapeut. Res., 1994, 55(1), 43-50.
[http://dx.doi.org/10.1016/S0011-393X(05)80076-1]
[5]
Kurocochi, Y.; Fukui, Y.; Adachi, N. Pharmacology of four imidazole derivatives related with histidine. Jpn. J. Pharmacol., 1956, 5(2), 132-138.
[http://dx.doi.org/10.1254/jjp.5.132] [PMID: 13331656]
[6]
Bertoni, S.; Ballabeni, V.; Flammini, L.; Saccani, F.; Domenichini, G.; Morini, G.; Comini, M.; Rivara, M.; Barocelli, E. In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. Naunyn Schmiedebergs Arch. Pharmacol., 2008, 378(3), 335-343.
[http://dx.doi.org/10.1007/s00210-008-0299-2] [PMID: 18496672]
[7]
Ferrari, F.; Baggio, G.; Mangiafico, V. Effects of imidazole and some imidazole-derivatives on lisuride-induced mounting and aggressiveness. Psychopharmacology (Berl.), 1987, 93(1), 19-24.
[http://dx.doi.org/10.1007/BF02439581] [PMID: 3114811]
[8]
Francesca, F.; Baggio, G. Influence of imidazole on behavioral effects induced by dopaminergic agonists in rats. Life Sci., 1985, 36(14), 1397-1405.
[http://dx.doi.org/10.1016/0024-3205(85)90046-3] [PMID: 2858800]
[9]
Karppanen, H.; Paakkari, P.; Orma, A.L.; Paakkari, I. Central hypotensive effects of imidazole acetic acid and rolipram (ZG 62711) in rats. Inflamm. Res., 1979, 84-85.
[10]
Tunnicliff, G. Pharmacology and function of imidazole 4-acetic acid in brain. Gen. Pharmacol., 1998, 31(4), 503-509.
[http://dx.doi.org/10.1016/S0306-3623(98)00079-2] [PMID: 9792207]
[11]
Jayappa, M.K.D.; Dasappa, J.P.; Puthallath, R.E.; Castelino, P.A. Synthesis and Pharmacological screening studies of some novel imidazo[2, 1-b] [1,3,4] thiadiazole. Pharma Chem., 2016, 8(5), 178-190.
[12]
Giles, K.; Berry, D.B.; Condello, C.; Dugger, B.N.; Li, Z.; Oehler, A.; Bhardwaj, S.; Elepano, M.; Guan, S.; Silber, B.M.; Olson, S.H.; Prusiner, S.B. Optimization of aryl amides that extend survival in prion-infected mice. J. Pharmacol. Exp. Ther., 2016, 358(3), 537-547.
[http://dx.doi.org/10.1124/jpet.116.235556] [PMID: 27317802]
[13]
Szacoń, E.; Rządkowska, M.; Kaczor, A.A.; Kędzierska, E.; Fidecka, S.; Matosiuk, D. Synthesis, central nervous system activity and structure-activity relationships of novel 1-(1-alkyl-4-aryl-4,5-dihydro-1H-imidazo)-3-substituted urea derivatives. Molecules, 2015, 20(3), 3821-3840.
[http://dx.doi.org/10.3390/molecules20033821] [PMID: 25730390]
[14]
Wei, P.H.L.; Bell, S.C. 2,3;4,5-substituted thiazoles. U.S. Patent 363,455, 1974.
[15]
Rządkowska, M.; Szacoń, E.; Kaczor, A.A.; Fidecka, S.; Kędzierska, E.; Matosiuk, D. Synthesis, central nervous system activity, and structure-activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones. Med. Chem. Res., 2014, 23, 4221-4237.
[http://dx.doi.org/10.1007/s00044-014-0993-1] [PMID: 25132789]
[16]
Zisterer, D.M.; Williams, D.C. Identification of novel ligands for the peripheral-type benzodiazepine receptor. Biochem. Soc. Trans., 1995, 23(2), 371S.
[http://dx.doi.org/10.1042/bst023371s] [PMID: 7672402]
[17]
Gagoria, J.; Verma, P.K.; Khatkar, A. Anticonvulsant and neurological profile of benzothiazoles: A mini-review. Cent. Nerv. Syst. Agents Med. Chem., 2015, 15(1), 11-16.
[http://dx.doi.org/10.2174/1871524915666150112094206] [PMID: 25578435]
[18]
Kamboj, V.K.; Verma, P.K.; Dhanda, A.; Ranjan, S.I. 2,4-triazole derivatives as potential scaffold for anticonvulsant activity. Cent. Nerv. Syst. Agents Med. Chem., 2015, 15, 17-22.
[19]
Mracec, M.; Borota, A.; Rad, R.; Ostopovici, L.; Mracec, M. Conformational analysis for a series of imidazole ligands acting as an antagonist on the histamine H3 receptor. Rev. Romain. Chim., 2007, 52(1-2), 201-206.
[20]
Merauer, J.Y.; Baron, F.; Ple, K.; Bonnet, P.; Routier, S. The azandole frame work in the design of kinase inhibitors. Molecules, 2014, 19, 19985-19979.
[21]
Cilibrasi, V. Polycyclic pyrrolo-thiazole systems with biological activity., PhD Thesis, Universita Deyli Studid Di Palermo. 2015.
[22]
Andreani, A.; Granaiola, M.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Calonghi, N.; Cappadone, C.; Farruggia, G.; Stefanelli, C.; Masotti, L.; Nguyen, T.L.; Hamel, E.; Shoemaker, R.H. Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action. J. Med. Chem., 2012, 55(5), 2078-2088.
[http://dx.doi.org/10.1021/jm2012694] [PMID: 22283430]
[23]
Dawood, K.M.; Farghaly, T.A. Thiadiazole inhibitors: A patent review. Expert Opin. Ther. Pat., 2016, 27(4), 477-505.
[24]
Ghabbour, H.A.; Kadi, A.A.; El-Tahir, K.E.H.; Angawi, R.F.; El-Subbagh, H.I. Synthesis, biological evaluation and molecular docking studies of thiazole based pyrrolidinones and isoindolidinones as anticonvulsant agents. Med. Chem. Res., 2015, 24(8), 3194-3211.
[http://dx.doi.org/10.1007/s00044-015-1371-3]
[25]
Harish, K.P.; Mohana, K.N.; Mallesha, L. Synthesis of pyrazine substituted 1,3,4-thiadiazole derivatives and their anticonvulsant activity. Org. Chem. Int., 2013, 2013631723https://www.hindawi.com/journals/oci/2013/631723/
[26]
Kolasa, K.; Kleinrok, Z.; Pietrasiewicz, T.; Czechowska, G.; Kieć-Kononowicz, K.; Zejc, A. Pharmacological studies on the central action of novel benzylidene-imidazothiazolone derivatives. Pol. J. Pharmacol. Pharm., 1989, 41(4), 377-383.
[PMID: 2576811]
[27]
Lafferty, T. Synthesis of a 1,2,4-substituted imidazole for a fragment- based drug discovery library. Honors Program Thesis. 2017.
[28]
Funderburk, W.H.; King, E.E.; Domino, E.F.; Unna, K.R. Pharmacological properties of benzazoles. II. Sites of action in the central nervous system. J. Pharmacol. Exp. Ther., 1953, 107(3), 356-367.
[PMID: 13035674]
[29]
de la Fuente, T.; Martín-Fontecha, M.; Sallander, J.; Benhamú, B.; Campillo, M.; Medina, R.A.; Pellissier, L.P.; Claeysen, S.; Dumuis, A.; Pardo, L.; López-Rodríguez, M.L. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists molecular. Mechanisms of receptor inactivation. J. Med. Chem., 2010, 53(3), 1357-1369.
[http://dx.doi.org/10.1021/jm901672k] [PMID: 20078106]
[30]
Pinderspacher, K.A. Six-membered ring systems. Progr. Heterocycl. Chem., 2015, 27, 393-450.
[http://dx.doi.org/10.1016/B978-0-08-100024-3.00013-1]
[31]
Asif, M. A brief review on antitubercular activity of pharmacological active some triazole analogues. Global J. Res. Rev, 2014, 1, (3), 051-058.
[32]
Chemie, B.G. Imidazole: Toxicological Evaluation. U.S. Patent 203, March 06, 2018.
[33]
Armenta, A.; Juan, S.S. Synthesis of 1,3-dihydro-2H-benzimidazole-2-ones (micro review). Chem. Heterocycl. Compd., 2016, 52(12), 1002-1004.
[http://dx.doi.org/10.1007/s10593-017-1999-7]
[34]
Mamedov, V.A.; Zhukova, N.A. Chapter 1-recent advances in the synthesis of benzimidazol-2-ones via rearrangements. Progr. Heterocycl. Chem, 2017, 29, 1-43.
[35]
Mamedov, V.A. Recent advances on the synthesis of benzimidazol-(on)es via rearrangements of quinoxalin(on)es. RSC Advances, 2016, 48, 1-6.
[http://dx.doi.org/10.1039/C6RA03907C]
[36]
Kamil, A.; Akhtar, S.; Karim, A.; Ahmed, A.; Wajdi, M.; Khan, Z.; Scify, Z.S. Benzimidazole derivative with potential cytotoxic activity-synthesis and their structure-activity relationship. FUUAST J., 2013, 3(2), 87-89.
[37]
Gamma, T.V.; Korenyuk, I.I. Effects of bemitel and benzimidazole on behavior of rats in open field test. Neurophysiology, 2006, 38(1), 75.
[http://dx.doi.org/10.1007/s11062-006-0028-8]
[38]
Mute, V.M.; Bodhankar, S.L. Potentiation of pressor effect of tyramine by newly synthesized compound 2[(n-benzylacetamido) mercapto) benzimidazole (vs. 25), a putative inhibitor of monoamine oxidase-enzyme in rats. Der. Pharmac. Lett., 2015, 6(6), 165-174.
[39]
Cernatescu, C.; Cobzaru, C.; Apostolescu, G.A.; Apostolescu, N.; Marinoiu, A. Quaternization of N-methylated phenyl-benzimi dazole azomethines to benzimidazolium salts. Rev. Raimain. Chim., 2016, 6-7(1), 591-596.
[40]
Dancius, C. New approaches to cancer prevention. Anti-Cancer Agent. Med. Chem., 2018, 18(5), 630.
[http://dx.doi.org/10.2174/187152061805180821111229]
[41]
Jose, C.V.; Anto, T.J. Studies on complexes of Cu2+ and Zn2+ metal ions with 2-(thiophene-2-formylimino) benzimidazole. Int. J. Chem. Sci., 2009, 7(4), 2541-2548.
[42]
Wildenberg, M.E.; Levin, A.D.; Ceroni, A.; Guo, Z.; Koelink, P.J.; Hakvoort, T.B.M.; Westera, L.; Bloemendaal, F.M.; Brandse, J.F.; Simmons, A.; D’Haens, G.R.; Ebner, D.; Van den Brink, G.R. Benzimidazoles promote anti-TNF mediated induction of regulatory macrophages and enhance therapeutic efficacy in murine model. J. Crohn’s Colitis, 2017, 11(12), 1480-1490.
[43]
Mamedov, V.A.; Shukova, N.A.; Sinyashin, O.G. Advances in the synthesis of benzimidazolones via rearrangements of benzodiazepinones and quinalin(on)es. Mendeleev Commun., 2017, 27, 1-11.
[http://dx.doi.org/10.1016/j.mencom.2017.01.001]
[44]
Shingare, R.D.; Kulkarni, A.S.; Sutar, R.L.; Reddy, D.S. Route to benzimidazol-2-ones via decarbonylative ring contraction of quinoxalinediones: application to the synthesis of flibanserin, a drug for treating hypoactive sexual desire disorder in women and marine natural product lunanamycin analogue. ACS Omega, 2017, 2(8), 5137-5141.
[http://dx.doi.org/10.1021/acsomega.7b00819] [PMID: 30023739]
[45]
Mamedov, V.A.; Zhukova, N.A.; Zamaletdinova, A.I.; Beschastnova, T.N.; Kadyrova, M.S.; Rizvanov, I.Kh.; Syakaev, V.V.; Latypov, S.K. Reaction for the synthesis of benzimidazol-2-ones, imidazo[5,4-b]-, and imidazo[4,5-c]pyridin-2-ones via the rearrangement of quinoxalin-2-ones and their aza analogues when exposed to enamines. J. Org. Chem., 2014, 79(19), 9161-9169.
[http://dx.doi.org/10.1021/jo501526a] [PMID: 25203611]
[46]
Tapia, I.; Alonso-Cires, L.; López-Tudanca, P.L.; Mosquera, R.; Labeaga, L.; Innerárity, A.; Orjales, A. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: Synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives. J. Med. Chem., 1999, 42(15), 2870-2880.
[http://dx.doi.org/10.1021/jm981098j] [PMID: 10425096]
[47]
Demont, E.H.; Bamborough, P.; Chung, C.W.; Craggs, P.D.; Fallon, D.; Gordon, L.J.; Grandi, P.; Hobbs, C.I.; Hussain, J.; Jones, E.J.; Le Gall, A.; Michon, A.M.; Mitchell, D.J.; Prinjha, R.K.; Roberts, A.D.; Sheppard, R.J.; Watson, R.J. 1,3-dimethyl benzimidazolones are potent, selective inhibitors of the BRPF1 bromodoman. ACS Med. Chem. Lett., 2014, 5(11), 1190-1195.
[http://dx.doi.org/10.1021/ml5002932] [PMID: 25408830]
[48]
Wee, X-K.; Ng, K-S.; Leung, H-W.; Cheong, Y-P.; Kong, K-H.; Ng, F-M.; Soh, W.; Lam, Y.; Low, C.M. Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor. Br. J. Pharmacol., 2010, 159(2), 449-461.
[http://dx.doi.org/10.1111/j.1476-5381.2009.00549.x] [PMID: 20082612]
[49]
Rice, C.A.; Colon, B.L.; Alp, M.; Göker, H.; Boykin, D.W.; Kyle, D.E. Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens. Antimicrob. Agents Chemother., 2015, 59(4), 2037-2044.
[http://dx.doi.org/10.1128/AAC.05122-14] [PMID: 25605363]
[50]
Ozkay, U.D.; Can, O.D.; Turan, N.; Cavusoglu, B.K. Synthesis and nociceptive activities of some novel benzimidazole-piperidine derivatives. Turk. J. Chem., 2017, 41, 672-682.
[http://dx.doi.org/10.3906/kim-1612-76]
[51]
Aleyasin, H.; Karuppagounder, S.S.; Kumar, A.; Sleiman, S.; Basso, M.; Ma, T.; Siddiq, A.; Chinta, S.J.; Brochier, C.; Langley, B.; Haskew-Layton, R.; Bane, S.L.; Riggins, G.J.; Gazaryan, I.; Starkov, A.A.; Andersen, J.K.; Ratan, R.R. Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin. Antioxid. Redox Signal., 2015, 22(2), 121-134.
[http://dx.doi.org/10.1089/ars.2013.5595] [PMID: 24766300]
[52]
Bethi, S.; Vidyasagar, M.; Rajamanohar, K.; Venkateshwar, R.J.; Gummudavelly, S. Synthesis and pharmacological evaluation of new benzimidazole derivatives. Der. Chim. Sin., 2011, 2(1), 84-90.
[53]
Galeotti, N.; Sanna, M.D.; Ghelardini, C. Pleiotropic effect of histamine H4 receptor modulation in the central nervous system. Neuropharmacology, 2013, 71, 141-147.
[http://dx.doi.org/10.1016/j.neuropharm.2013.03.026] [PMID: 23583928]
[54]
Saito, T.; Fukuda, T.; Sukamoto, T.; Yashidomi, M.; Morimoto, Y.; Shimohara, K.; Ito, K.I. Homopiperazinyl benzimidazole difumarate,1st communication: Effect on the central nervous system. Arzneimittelforschung, 1988, 38(1), 66-69.
[PMID: 2896509]
[55]
Thompson, Jr, H.G.; Hirschberg, E.; Zaidenweber, J.; Gelhorn, A. Toxicological and clinical evolution of a new nitrogen mustard, 2-[di-(2-chloroethyl)-aminomethyl] benzimidazole. Cancer Res., 1959, 19, 719-725.
[56]
Marshall, F.N.; Jones, W.R.; Weaver, L.C. Comparison of pharmacologic activity in a series of benzimidazole compounds. Proc. Soc. Exp. Biol. Med., 1964, 116, 912-914.
[http://dx.doi.org/10.3181/00379727-116-29406] [PMID: 14230387]
[57]
Sasmal, K.; Sasmal, S.; Abbineni, G.; Venkatesham, B.; Rao, P.T.; Roshaiah, M.; Khanna, I.; Sebastian, V.J.; Singh, M.P.; Talwar, R.; Shashikumar, D.; Reddy, K.H.; Frimurer, T.M.; Rist, O.; Elster, L.; Hogberg, T. Synthesis and SAR studies of benzimidazole derivatives as melanin concentrating hormone receptor 1(MCHRI) antagonists: Focus to detune hERG inhibition. MedChemComm, 2011, 2, 385-389.
[58]
Dedrieka, V.B.I. Inhibition of monoamine oxidase B by substituted benzimidozole analogues. Bioorg. Med. Chem., 2006, 15(11), 3692-3702.
[59]
Sarnpitak, P.; Mujumdar, P.; Morisseau, C.; Hwang, S.H.; Hammock, B.; Iurchenko, V.; Zozulya, S.; Gavalas, A.; Geronikaki, A.; Ivanenkov, Y.; Krasavin, M. Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core. Eur. J. Med. Chem., 2014, 84, 160-172.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.023] [PMID: 25016374]
[60]
Julia, L.; Tozakidis, L.E.P.; Prachee, B.; Hans-Joachim, G. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation; Information System Division, National Agricultural Library, 2013.
[61]
Ai, J.; Wang, X.; Wahe, H.; Fomum, Z.T.; Sterner, O.; Nielsen, M.; Witt, M.R. 2-Oxo-2H-Pyrimido[2,1-b]benzothiazoles inhibit brain benzodiazepine receptor binding in vitro. Pharmacology, 2000, 60(4), 175-178.
[http://dx.doi.org/10.1159/000028366] [PMID: 10828741]
[62]
Saganuwan, S.A. Functional chemical groups that may likely become a source for synthesis of central nervous acting drugs. Cent. Nerv. Syst. Agents Med. Chem., 2017, 17(3), 178-186.
[http://dx.doi.org/10.2174/1871524917666170502153752]
[63]
Marek, A.; Kulhanek, J.; Ludwig, M.; Bures, F. Facile synthesis of optically active imidazole derivatives. Molecules, 2007, 12(5), 1183-1190.
[http://dx.doi.org/10.3390/12051183] [PMID: 17873852]
[64]
Yaylayan, V.A.; Haffenden, L.J.W. Mechanism of imidazole and oxazole formation in [13C-2]-labelled glycine and alanine model systems. Food Chem., 2003, 81, 403-409.
[http://dx.doi.org/10.1016/S0308-8146(02)00470-3]
[65]
Lantios, J.; Gombartz, K.; McGuire, M.; Pridgen, L.; Remich, J.; Shicrat, S. Synthetic and mechanistic studies on the preparation of pyridyl-substituted imidazothiazoles. J. Org. Chem., 1988, 53, 4223-4227.
[http://dx.doi.org/10.1021/jo00253a012]
[66]
Shetty, N.S.; Khazi, I.A.M.; Ahn, C. Synthesis, anthelmintic and anti-inflammatory activities of some novel imidazothiazole sulfides and sulfones. Bull. Korean Chem. Soc., 2010, 31(8), 2337-2340.
[http://dx.doi.org/10.5012/bkcs.2010.31.8.2337]
[67]
Fik, C.P.; Krumm, C.; Muennig, C.; Baur, T.I.; Salz, U.; Bock, T.; Tiller, J.C. Impact of functional satellite groups on the antimicrobial activity and hemocompatibility of telechelic poly(2-methyl oxazoline)s. Biomacromolecules, 2012, 13(1), 165-172.
[http://dx.doi.org/10.1021/bm201403e] [PMID: 22148422]
[68]
Huang, K-S.; Yang, C-H.; Huang, S-L.; Chen, C-Y.; Lu, Y-Y.; Lin, Y-S. Recent advances in antimicrobial polymers: a mini-review. Int. J. Mol. Sci., 2016, 17(9), 1-14.
[http://dx.doi.org/10.3390/ijms17091578] [PMID: 27657043]
[69]
Reyes-Areliano, A.; Gomez-Garcia, O.; Torres-Jaramillo, J. Synthesis of azolines and imidazoles and their use in drug design. Med. Chem., 2016, 6(9), 561-570.
[70]
Bland, B.H. The physiology and pharmacology of hippocampal formation theta rhythms. Prog. Neurobiol., 1986, 26(1), 1-54.
[http://dx.doi.org/10.1016/0301-0082(86)90019-5] [PMID: 2870537]
[71]
Klebe, G.; Dullweber, F.; Bohm, H-J. Thermodynamic models of drug-receptor interactions: A general introduction.In: Drug-Receptor Thermodynamics: Introduction and Applications; Raffa, R.B., Ed.; Wiley: New Jersey, 2001, pp. 83-104.
[72]
Silverman, R.B. Drug-receptor interactions: The Organic Chemistry of Drug Design and Drug Action; Elsevier Academic Press: Massachusetts, 2004, pp. 123-131.
[73]
Motiejunas, D.; Wade, R.C. Structural, energetic and dynamic aspects of ligand-receptor interactions. Compr. Med. Chem., 2007, 4, 193-213.
[http://dx.doi.org/10.1016/B0-08-045044-X/00250-9]
[74]
Di Cera, E. Thermodynamic Theory of Site-specific Binding Processes.In: Biological Macromolecules; Cambridge University Press: Cambridge, UK, 1995.
[http://dx.doi.org/10.1017/CBO9780511524837]
[75]
Schaeffer, L. The role of functional groups in drug-receptor interactions.In: The Practice of Medicinal Chemistry; Elsevier: Netherlands, 2009, pp. 359-378.
[76]
Singh, L.; Kulshrestha, R.; Singh, N.; Jaggi, A.S. Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection. Korean J. Physiol. Pharmacol., 2018, 22(3), 225-234.
[http://dx.doi.org/10.4196/kjpp.2018.22.3.225] [PMID: 29719445]
[77]
Hunter, C.A.; Tomas, S. Cooperativity, partially bound states, and enthalpy-entropy compensation. Chem. Biol., 2003, 10(11), 1023-1032.
[http://dx.doi.org/10.1016/j.chembiol.2003.10.009] [PMID: 14652069]
[78]
Mobini, K.A.; Hamta, A.; Kalhor, M.; Shariatzadeh, M. Simple synthesis and biological evaluation of some benzimidazoles using sodium hexafluroaluminate, Na AlF6 as an efficient catalyst. Iran. J. Pharm. Res., 2014, 13(1), 95-101.
[PMID: 24734060]
[79]
Amirmostofian, M.; Pourahmad Jaktaji, J.; Soleimani, Z.; Tabib, K.; Tanbakosazan, F.; Omrani, M.; Kobarfard, F. Synthesis and molecular-cellular mechanistic study of pyridine derivative of dacarbazine. Iran. J. Pharm. Res., 2013, 12(3), 255-265.
[PMID: 24250631]
[80]
Grimmett, M.R. Imidazole and Benzimidazole Synthesis; Harcourt Brace and Company Publishers: California, USA, 1997, pp. 1-94.
[81]
Ranji, K.; Abdul Baguee, A. New particle: An overview of preparation, characterization and application. Int. Res. J. Pharm., 2013, 4(4), 47-57.
[82]
Kearney, J.A.F.; Frey, K.A.; Albin, R.L. Metabotropic glutamate against induced rotation: pharmacological FOS and (11C)-2-deoxyglucose autoradiography study. J. Neurotoxicol., 1997, 17(11), 4415-4425.
[PMID: 9151758]
[83]
Pavan, B.; Dalpiaz, A.; Ciliberti, N.; Biondi, C.; Manfredini, S.; Vertuani, S. Progress in drug delivery to the central nervous system by the prodrug approach. Molecules, 2008, 13(5), 1035-1065.
[http://dx.doi.org/10.3390/molecules13051035] [PMID: 18560328]
[84]
Ghose, A.K.; Herbertz, T.; Hudkins, R.L.; Dorsey, B.D.; Mallamo, J.P. Knowledge-based central nervous system (CNS) lead selection and lead optimization for CNS drug discovery. ACS Chem. Neurosci., 2012, 3(1), 50-68.
[http://dx.doi.org/10.1021/cn200100h] [PMID: 22267984]
[85]
Hurko, O.; Ryan, J.L. Translational research in central nervous system drug discovery. NeuroRx, 2005, 2(4), 671-682.
[http://dx.doi.org/10.1602/neurorx.2.4.671] [PMID: 16489374]
[86]
Gogoi, P.; Konwar, D. An efficient and one-pot synthesis of imidazolines and benzimidazoles via anaerobic oxidation of carbon-nitrogen bonds in water. Tetrahedron Lett., 2006, 47, 79-82.
[http://dx.doi.org/10.1016/j.tetlet.2005.10.134]

© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version466msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[23:47:59] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[23:47:59] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[23:47:59] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (101ms)time
  • Application (365ms)time
  • 1 x Application (78.3%)
    365ms
    1 x Booting (21.7%)
    101ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    32 statements were executed, 4 of which were duplicates, 28 unique. Show only duplicated279ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('59765840','',1,1740700079,1740700079) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740700079
      1.11msalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('59765840','/article/99164',1,1740700079,1740700079)
      820μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 59765840 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59765840) limit 1
      31.37msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 59765840
      • 1: 59765840
      • 2: 59765840
      • 3: 59765840
      • 4: 59765840
      • 5: 59765840
      • 6: 59765840
      • 7: 59765840
      • 8: 59765840
      • 9: 59765840
      • 10: 59765840
      • 11: 59765840
      • 12: 59765840
      • 13: 59765840
      • 14: 59765840
      • 15: 59765840
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=99164
      980μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 36 limit 1
      1.08msalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 36
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=36) and sj.journal_id!=36 group by `j`.`nid`) as `aggregate_table`
      1.7msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=36) and sj.journal_id!=36 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      1.43msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=36) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      4.35msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=36) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      2.53msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '99164'
      1.6msalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 99164
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '99164'
      4.71msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 99164
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '99164' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      3.04msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 99164
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      320μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      650μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 36 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      25.87msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 36 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      5.75msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 36 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      4.18msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 99164 limit 1
      1.24msalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 99164
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 99164 and content_type = 'article' order by status desc limit 1
      1.41msalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid article_nid,a.title article_title,j.title journal_title from content_by_diseases cd inner join article a on a.article_id=cd.content_id inner join journal j on j.journal_id=a.journal_id where cd.pid = 281 and cd.sub_disease_id = 297 and content_id!=99164 and cd.content_type = 'article' order by rand() limit 20
      178msalphaeurekaselec_live_10_06_2022Article.php#769
      Backtrace
      • 11. app/Models/Article.php:769
      • 12. app/Http/Controllers/ArticleController.php:2098
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 172936 limit 1
      210μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 172936
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      200μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'CNSAMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      240μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: CNSAMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '99164' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      400μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '3' and is_uploaded = 1 and issue_id = 9695 order by cast(first_page as SIGNED) desc limit 1
      410μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 3
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '12' and is_uploaded = 1 and issue_id = 9695 order by cast(first_page as SIGNED) asc limit 1
      350μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 12
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      160μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      160μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 99164 limit 1
      2.3msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 99164
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 36 and `b`.`banner_from_date` <= 1740700079 and `b`.`banner_to_date` >= 1740700079 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.14msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 36
      • 3: 1740700079
      • 4: 1740700079
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 36 and `b`.`banner_from_date` <= 1740700079 and `b`.`banner_to_date` >= 1740700079 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.14msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 36
      • 3: 1740700079
      • 4: 1740700079
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='72df87888207966729ee16eb274db2a4'
      250μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        JrnIYmVW93VLT25HfbM2khrkSFQkEjn5TWx8fvkb
        uc_cart_id
        72df87888207966729ee16eb274db2a4
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/99164" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/99164
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:8 [ "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        []
        
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Thu, 27 Feb 2025 23:47:59 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImFac1NqSXAyeHp4emlSSzExdmJkZWc9PSIsInZhbHVlIjoiYW5RZ2cyMGZSRDZVZXNWdGFqQTZpMFlPSnp5ck1YZHhyUlhHTm9TN0NUMkV3RSs1UlpUVk9BUVRweWNyLzE1ZFlWRFRxbldIOGdhSkdVTnpZUVhFSTRYWGs5MTMxb254SjR2bzB6MHArazFuRFAxMWh0R0YxRTRTV2dSWmFodlciLCJtYWMiOiI2ZDI4YmVkN2NlOGM1N2U0ZGM0Yzk3NGE2NDIzZWI4MTBlYjc1MjVkNjdkZGFmNzk1MTIxMTIyOTE4OTAxZGUyIiwidGFnIjoiIn0%3D; expires=Sun, 02 Mar 2025 11:47:59 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6ImFac1NqSXAyeHp4emlSSzExdmJkZWc9PSIsInZhbHVlIjoiYW5RZ2cyMGZSRDZVZXNWdGFqQTZpMFlPSnp5ck1YZHhyUlhHTm9TN0NUMkV3RSs1UlpUVk9BUVRweWNyLzE1ZFlWRFRxb" 1 => "alphaeurekaselectnet_session=eyJpdiI6ImFZaDhyMVNyZUVGV0praFJkMjNVdFE9PSIsInZhbHVlIjoiQnBmaDVGRXBsNTdneWd2WmFCNUpEVjBYb0lremYwcS9LZ3RLQ1lLeU14czFyZ2JzUXVKZ0ZROHkwSUJHazQ3K3h6dFNuS3Zva0RseHljTkRSUmRQQndsTnlEd3pIVkdpeUJ2aUhsVnhOZXJYWk1SQ2d6MTg5MWxkaUdpRyszWkciLCJtYWMiOiI1NmQzZTY5NWQ0ZmNlODg0ZDIzN2IxMzE3YmFhMGM2NTI1OTgyMGVhNmRhY2VlNDA4NWQ4MzYxMGYwMmI3YzRmIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6ImFZaDhyMVNyZUVGV0praFJkMjNVdFE9PSIsInZhbHVlIjoiQnBmaDVGRXBsNTdneWd2WmFCNUpEVjBYb0lremYwcS9LZ3RLQ1lLeU14czFyZ2JzUXVKZ0ZROHk" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImFac1NqSXAyeHp4emlSSzExdmJkZWc9PSIsInZhbHVlIjoiYW5RZ2cyMGZSRDZVZXNWdGFqQTZpMFlPSnp5ck1YZHhyUlhHTm9TN0NUMkV3RSs1UlpUVk9BUVRweWNyLzE1ZFlWRFRxbldIOGdhSkdVTnpZUVhFSTRYWGs5MTMxb254SjR2bzB6MHArazFuRFAxMWh0R0YxRTRTV2dSWmFodlciLCJtYWMiOiI2ZDI4YmVkN2NlOGM1N2U0ZGM0Yzk3NGE2NDIzZWI4MTBlYjc1MjVkNjdkZGFmNzk1MTIxMTIyOTE4OTAxZGUyIiwidGFnIjoiIn0%3D; expires=Sun, 02-Mar-2025 11:47:59 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6ImFac1NqSXAyeHp4emlSSzExdmJkZWc9PSIsInZhbHVlIjoiYW5RZ2cyMGZSRDZVZXNWdGFqQTZpMFlPSnp5ck1YZHhyUlhHTm9TN0NUMkV3RSs1UlpUVk9BUVRweWNyLzE1ZFlWRFRxb" 1 => "alphaeurekaselectnet_session=eyJpdiI6ImFZaDhyMVNyZUVGV0praFJkMjNVdFE9PSIsInZhbHVlIjoiQnBmaDVGRXBsNTdneWd2WmFCNUpEVjBYb0lremYwcS9LZ3RLQ1lLeU14czFyZ2JzUXVKZ0ZROHkwSUJHazQ3K3h6dFNuS3Zva0RseHljTkRSUmRQQndsTnlEd3pIVkdpeUJ2aUhsVnhOZXJYWk1SQ2d6MTg5MWxkaUdpRyszWkciLCJtYWMiOiI1NmQzZTY5NWQ0ZmNlODg0ZDIzN2IxMzE3YmFhMGM2NTI1OTgyMGVhNmRhY2VlNDA4NWQ4MzYxMGYwMmI3YzRmIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6ImFZaDhyMVNyZUVGV0praFJkMjNVdFE9PSIsInZhbHVlIjoiQnBmaDVGRXBsNTdneWd2WmFCNUpEVjBYb0lremYwcS9LZ3RLQ1lLeU14czFyZ2JzUXVKZ0ZROHk" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "JrnIYmVW93VLT25HfbM2khrkSFQkEjn5TWx8fvkb" "uc_cart_id" => "72df87888207966729ee16eb274db2a4" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/99164" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-27 23:47:59GET/article/99164314321